Research-based evidence suggests that PPARγ mediates the effect of liver-protective docosahexaenoic acid in ameliorating liver fibrosis by inducing cell cycle arrest and apoptosis in HSCs (95). Here, PPARG is linked to Hepatic fibrosis.